Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Quarterly Report Quartiers Properties – July to September 2021

Quartiers Properties AB (publ) has today published the company’s quarterly report for the period July to September 2021.Summary of the period JULY – SEPTEMBER 2021: Record operating cash flow in the quarter · Net sales for the third quarter amounted to a record SEK 70,574 (17,533) thousand. In comparison, sales for the full year 2020 amounted to SEK 55,800 thousand. Sales are also significantly higher than in the second quarter of 2021, when the total was SEK 25,505 thousand. · The company's cash flow from operating activities, including residential sales, amounted to SEK 32,680 (

Conotoxia Pay: payment link as a new solution for e-commerce

Online shops using Conotoxia Pay can now use the payment link service. Thanks to this feature, stores can generate and send online payment links, which allow their customers to pay for their orders within seconds.The payment link service for merchants is a fast, convenient and secure way to accept one-time payments from online shoppers. E-commerce owners, taking advantage of the Conotoxia Pay system, can send customers a link via any messenger, email or any other form of electronic contact. The link, with a set expiry date, directs the buyer straight to the payment processing. The e-

BioStock: Successful outcome of Chordate Medical’s warrant

Chordate Medical receives 35.6 MSEK before issue costs through the exercise of the warrants of series TO7. The subscription rate was 99.23 per cent and major shareholders exercised all their warrants. BioStock contacted CEO Anders Weilandt for a comment.Read the full article at biostock.se: https://www.biostock.se/en/2021/11/successful-outcome-of-chordate-medicals-warrant/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

BioStock: CombiGene are looking for broader opportunities

The EU decision to invest 3.36 MEUR in CombiGene’s development of gene therapy epilepsy treatment CG01 recently bore fruit as the company entered into an agreement with Spark Therapeutics for further development of the candidate. BioStock reached out to CEO Jan Nilsson for a comment as the company just received their last payment from the EU programme Horizon 2020. Strengthened by the large grant and triumphant deal, the company is looking to broaden its focus going forward.Read the article at biostock.se : https://www.biostock.se/en/2021/11/combigene-are-

Azelio partners with 24 companies to accelerate decarbonisation with Long Duration Energy Storage

Azelio is a member of the Long Duration Energy Storage Council launched during COP26 in Glasgow. Together with 24 other technology companies, users and investors, we are accelerating the work towards grid net-zero by 2040.25 companies have united to provide guidance to governments and grid operators on Long Duration Energy Storage (LDES) technologies, which supply clean power 24 hours a day. The aims are to enable global deployment of 85-140 TWh of long duration energy storage by 2040, to eliminate the 1.5 to 2.3 Gt of CO2 produced annually from fossil fuels, and address grid energy

Alfa Laval is part of the new Long Duration Energy Storage Council to accelerate carbon neutrality

Today at COP26 in Glasgow, UK, Alfa Laval announced its participation in the Long Duration Energy Storage (LDES) Council. Formed by technology companies, users and investors to achieve grid net-zero by 2040, the council will support governments, grid operators and major electricity users in adopting the most cost-effective energy storage solutions to replace the use of fossil fuels.To achieve decarbonization, significant efforts must be made to reduce emissions across all sectors. The power sector, which accounts for roughly one-third of global emissions, is central to global

Konftel Calls For Change As World Leaders Gather For Major Climate Summit

Konftel is urging the wider communications industry to follow its lead and take the greener route to success – after enabling customers to ‘conference with a clear climate conscience’.With the COP26 UN climate change conference now underway in Glasgow, Konftel has issued a rallying call having become the first manufacturer of its kind to achieve Climate Neutral certification. In an era of agile working with huge demand for conferencing and collaboration hardware, protecting the planet is just as important as connecting the world, says CMO Stefan Eriksson. “We were the first in the

Novedo has secured SEK 150 million pre-IPO private placement and contemplates issuance of a SEK denominated senior secured bond

In October 2021, Novedo Holding AB (publ) (“Novedo” or the “Company”) secured a SEK 150 million pre-IPO private placement where ABG Sundal Collier AB acted as financial advisor to the Company. To address the strong investor demand, the Company decided to increase the offering size of the pre-IPO private placement from SEK 100 million to SEK 150 million. The investment will be used to support future growth through actively acquiring companies with driven entrepreneurs, strong market positions and solid financial track record. Furthermore, Novedo has mandated ABG Sundal Collier AB and

Finnair complements Turku and Tampere flight connections with bus connections to lower the CO2 footprint of the route as of summer 2022

Finnair will resume flights to two of its domestic destinations, Turku and Tampere, where flight connections have been on hold since spring 2020 due to the pandemic. Finnair will complement the flight connections to Turku and Tampere with a new type of bus connection, to reduce the CO2 footprint of these routes. The routes are among the shortest in Finnair network, although they have been operated with energy-efficient ATR aircraft, their emissions load per passenger is clearly heavier than on other routes.   “Turku and Tampere are an important part of our network. Traveling on these

Invitation to Readly’s Q3 presentation on 11 November

Readly AB will publish its interim report for the third quarter 2021 on 11 November at 07:30 CET. The report will be presented in an audiocast and teleconference at 09.00 CET the same day.Maria Hedengren, CEO and Johan Adalberth, CFO, will present the report and answer questions. The presentation will be held in English.To listen to the conference by phone, please call:SE: +46850558368UK: +443333009030US: +18335268395Follow the presentation live on:Link to audiocast Report and presentation will be available for download

Executive Brief from CEO Michael Glantz: “Our new strategy yield results”

In October, it was 18 months since Michael Glantz became the CEO of myFC. In this Executive Brief, he shares his thoughts on the company's development and the news that has been communicated recently. His report exudes optimism and confirms that the change of strategy to B2B was the right decision.“In my first Executive Brief, I spoke about a number of challenges the company faced. I was then almost three months into my new position as CEO, after working for many years as CTO at the company. Today, just over a year later, a lot has happened. There are several interesting topics to reflect

Aker ASA: Information regarding dividend sent to shareholders due to an error

Due to an error, all shareholders have today received information regarding dividend payment of NOK 11.75 in November 2021. The dividend decision is on the agenda for consideration in today’s Board of Directors meeting in Aker ASA. The company will inform the market of any relevant decision when taken. -ENDS- For more information, please contact: Joachim Bjørni, Head of Investor Relations, Aker ASATel: +47 924 22 106E-mail: joachim.bjorni@akerasa.com Atle Kigen, Head of Media Relations and Public Affairs, Aker ASATel: +47 907 84 878Email: atle.kigen@akerasa.com This

Nomination Committee for Elicera Therapeutics appointed

Gothenburg, November 4, 2021 – Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company that develops immuno-oncological treatments focused on CAR T-cells and oncolytic viruses, announces that representatives of the largest owners have appointed the nomination committee ahead of the Annual General Meeting  2022.On April 26, the Annual General Meeting established rules to guide the work of the Nomination Committee. The three largest owners on September 30 2021, were Magnus Essand, Di Yu and Jamal El-Mosleh, who together control 47.1% of the votes, and will be the

Inhalation Sciences to present at Redeye Life Science Day November 11

(Stockholm, 4 November, 2021) Inhalation Sciences (ISAB) CEO Manoush Masarrat will present the latest developments for the company at Redeye Life Science Day on November 11. ISAB provide high-precision equipment and research services for aerosol and inhalation studies that can de-risk drug development projects.Redeye Life Science Day is a digital event where up to 50 companies will present their business and technologies, and take questions from  analysts and experts. The presentation is live broadcasted and can be followed at:  https://www.redeye.se/events/815899/redeye-life-science-day-

Terveystalo Plc: SHARE REPURCHASE 3.11.2021

Terveystalo Plc ANNOUNCEMENT  3.11.2021 Terveystalo Plc: SHARE REPURCHASE 3.11.2021 In the Helsinki Stock Exchange Trade date           3.11.2021Bourse trade         BuyShare                  TTALOAmount             17 000 SharesAverage price/ share    11,2598 EURTotal cost            191 416,60 EUR Terveystalo Plc now holds a total of 801 000 sharesincluding the shares repurchased on 3.11.2021 On behalf of Terveystalo Plc Nordea Bank Oyj Janne

Change to Date of Interim Report

Ayima today announces that it will change the date of the release of the Q3 Interim report, currently scheduled for November 26, 2021. The new date for the release will be November 8, 2021. The reason for the change is improved accounting and audit procedures have meant that the report will be completed signifantly earlier than previously expected. In light of these improved procedures, Ayima will also re-assess the scheduled dates for the release of subsequent reports and notify the market when the new dates have been decided.

INVISIO receives order for 40 Intercom systems from a European NATO country

INVISIO has received an order for 40 Intercom systems. The customer is a European NATO country. The order is the first somewhat substantial commercial follow-up order and thus significant for future marketing of the system. The order value is less than SEK 10 million. After an extensive evaluation process of the Intercom system the customer placed an order for another 40 or so systems. The customer intends to mount the systems in light transport vehicles, to enable effective internal communication while traveling. Interest in the Intercom system is great and since its launch several

BioStock: PolarCool’s presence in France gets local media boost

Between September and October, PolarCool signed two six-week evaluation agreements to introduce its brain cooling device PolarCap in France. Both agreements are with top-league ruby teams within the country. The local media sees the transactions as an important development for French Rugby, which has seen the amount of head injuries increase in recent years.Read the article at biostock.se : https://www.biostock.se/en/2021/11/polarcools-presence-in-france-gets-local-media-boost/ This is a press release from BioStock - Connecting Innovation & Capital. https:/

Q3 Report 2021 – invitation to conference call and audiocast

Stockholm, November 4, 2021 - On Tuesday, November 9, at 09.00 CET, IRRAS will host a conference call and an online presentation of its Q3 2021 interim report (which will have been published earlier on November 9 at 08.00 CET). The presentation will be held in English. The dial-in numbers for the conference call are:Sweden: +46 8 50 55 83 59Rest of the world: +44 33 33 00 92 71 The presentation will be webcast and can be accessed from the following web address: https://tv.streamfabriken.com/irras-q3-2021 Speakers: President and CEO Will Martin, Interim CFO Griffen Stapp, and

Invitation to presentation of Balco’s third quarter report 2021

Balco’s interim report for the third quarter 2021 will be published at 07:30 CET on November 18, 2021. A web-cast telephone conference will be held at 09:00 CET the same day, where CEO and President Kenneth Lundahl and CFO Michael Grindborn will present the results for the third quarter 2021.A possibility will be given to ask questions via the webcast and follow the presentation material live. The webcast, which afterwards also will be available on demand, will be accessible at Balco’s financial website, www.balcogroup.se or via the following link: https://tv.streamfabriken.com/balco-q3-

DBP International: Signed a collaboration partnership agreement with Alexavi for commercialization of Temodex®

Double Bond Pharmaceutical International AB (publ) (“DBP” or “Double Bond”) has entered into a collaborative partnership with Alexavi Ltd (“Alexavi”). This is a major step in Double Bond’s development process and marks the company’s commitment to move forward towards approval and commercialisation of Temodex® program, for the treatment of Glioblastoma. This collaboration will open up accessibility to a ground-breaking treatment paradigm in this therapeutic area.  Alexavi will be managing an Early Access to Treatment program on behalf of Double Bond to raise awareness of the treatment’s

NORDEN initiates share buy-back programme

ANNOUNCEMENT NO. 75 - 4 NOVEMBER 2021 The Board of Directors has decided to carry out a share buy-back of up to a total of USD 40 million (approximately DKK 263 million). The share buy-back programme is initiated pursuant to the authorisation granted to the Board of Directors, which entitles NORDEN to acquire treasury shares at a nominal value not exceeding 10% of the share capital at the market price applicable at the time of acquisition with a deviation of up to 10%. This authorisation was most recently renewed at NORDEN’s general meeting on 25 March 2021. PurposeThe purpose of

Nordea cancels repurchased shares

Nordea Bank AbpStock exchange release – Total number of voting rights and capital4 November 2021 at 9.15 EETNordea Bank Abp (“Nordea”) has today cancelled 42,602,988 treasury shares, which were held for capital optimisation purposes and acquired through share buy-backs, in line with the decision by the Board of Directors.The cancellation of the treasury shares has been registered with the Finnish Trade Register on 4 November 2021. After the cancellation, the total number of shares in Nordea is 4,007,348,931 and the total number of votes attached to the shares is 4,007,348,931.

NORDEN REPORTS BEST QUARTERLY RESULT IN 10 YEARS

ANNOUNCEMENT NO. 74 - 4 NOVEMBER 2021 For the third quarter of 2021, NORDEN reports a result of USD 65 million - the best quarterly in 10 years. This is driven by excellent Dry Operator results, capitalising on significant dry cargo rate increases and high market exposure by having secured T/C capacity early in the year at much lower costs. NORDEN has actively converted increases in the market value of its portfolio to profit through vessel sales, providing sales gains of USD 13 million in Q3. Expecting a very strong Q4 result driven by a strong position in Dry Operator, and

There are no items matching the current filter
There are no more items matching the current filter
Back to top